CPT: Pharmacometrics & Systems Pharmacology (Nov 2021)

A framework to guide dose & regimen strategy for clinical drug development

  • Oliver Sander,
  • Baldur Magnusson,
  • Inga Ludwig,
  • Astrid Jullion,
  • Christophe Meille,
  • Daniel Lorand,
  • Björn Bornkamp,
  • Markus Hinder,
  • Steven J. Kovacs,
  • Michael Looby

DOI
https://doi.org/10.1002/psp4.12701
Journal volume & issue
Vol. 10, no. 11
pp. 1276 – 1280

Abstract

Read online

Abstract Optimizing new drug therapies remains a challenge for clinical development, despite the use of ever more sophisticated quantitative methodologies. Although conceptually simple, the idea of finding the right treatment at the right dose for the right patient to ensure an appropriate balance of risks and benefits is challenging and requires a multidisciplinary approach. In this paper, we present a framework developed as a tool for organizing knowledge and facilitating collaboration in development teams.